Membrane permeable cyclic peptidyl inhibitors against human peptidylprolyl isomer ase pin1

Journal of Medicinal Chemistry

Volumn 53, Issue 6, 2010, Pages 2494-2501

  Liu, Tao ^a   Liu, Yu ^b   Kao, Hung Ying ^b   Pei, Dehua ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE; BETA ACTIN; CYCLIC PEPTIDYL INHIBITOR; PEPTIDE LIBRARY; PEPTIDYLPROLYL ISOMERASE PIN1; PROMYELOCYTIC LEUKEMIA PROTEIN; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CARCINOMA CELL; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DESIGN; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; PROTEIN MOTIF; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CALORIMETRY; CATALYSIS; CATALYTIC DOMAIN; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HELA CELLS; HUMANS; KINETICS; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PEPTIDYLPROLYL ISOMERASE;

EID: 77949860245     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm901778v     Document Type: Article

References (47)

1. Fischer, G.; Aumuller, T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 2003, 148, 105-150.
2. Lu, P. J.; Zhou, X. Z.; Shen, M. H.; Lu, K. P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283, 1325-1328.
3. Yaffe, M. B.; Schutkowski, M.; Shen, M. H.; Zhou, X. Z.; Stukenberg, P. T.; Rahfeld, J. U.; Xu, J.; Kuang, J.; Kirschner, M. W.; Fischer, G.; Cantley, L. C.; Lu, K. P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278, 1957-1960.
4. Lu, K. P.; Zhou, X. Z. The prolyl isomerase Pinl: a pivotal new twist in phosphorylation signaling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8, 904-916.
5. Crenshaw, D. G.; Yang, J.; Means, A. R.; Kornbluth, S. The mitotic peptidyl-prolyl isomerase, Pinl, interacts with Cdc25 and Plx1. EMBO J. 1998, 17, 1315-1327.
6. Stukenberg, P. T.; Kirschner, M. W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 2001, 7, 1071-1083.
7. Zhou, X. Z.; Kops, O.; Werner, A.; Lu, P. J.; Shen, M. H.; Stoller, G.; Kullertz, G.; Stark, M.; Fischer, G.; Lu, K. P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 5, 873-883.
8. Okamoto, K.; Sagata, N. Mechanism for inactivation of the mitotic inhibitory kinase Weel at M phase. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 3753-3758.
9. Albert, A. L.; Lavoie, S.; Vincent, M. A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pinl. J. Cell Sci. 1999, 112, 2493-2500.
10. Xu, Y. X.; Manley, J. L. The prolyl isomerase Pin1 functions in mitotic chromosome condensation. Mol. Cell 2007, 26, 287-300.
11. Wulf, G. M.; Ryo, A.; Wulf, G. G.; Lee, S. W.; Niu, T. H.; Petkova, V.; Lu, K. P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20, 3459-3472.
12. Liou, Y. C.; Ryo, A.; Huang, H. K.; Lu, P. J.; Bronson, R.; Fujimori, F.; Uchida, T.; Hunter, T.; Lu, K. P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-nullphenotypes. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 1335-1340.
13. Yeh, E. S.; Lew, B. O.; Means, A. R. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 2006, 281, 241-251.
14. Yeh, E.; Cunningham, M.; Arnold, H.; Chasse, D.; Monteith, T.; Ivaldi, G.; Hahn, W. C.; Stukenberg, P. T.; Shenolikar, S.; Uchida, T.; Counter, C. M.; Nevins, J. R.; Means, A. R.; Sears, R. A signaling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 5, 308-318.
15. Zacchi, P.; Gostissa, M.; Uchida, T.; Salvagno, C.; Avolio, F.; Volinia, S.; Ronai, Z.; Blandino, G.; Schneider, C.; Del Sal, G. The prolyl isomerase Pinl reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419, 853-857.
16. Zheng, H.; You, H.; Zhou, X. Z.; Murray, S. A.; Uchida, T.; Wulf, G.; Gu, L.; Tang, X. R.; Lu, K. P.; Xiao, Z. X. J. The proly1 isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419, 849-853.
17. Berger, M.; Stahl, N.; Del Sal, G.; Haupt, Y. Mutations in proline 82 of p53 impair its activation by Pinl and Chk2 in response to DNA damage. Mol. Cell. Biol. 2005, 25, 5380-5388.
18. Mantovani, F.; Piazza, S.; Gostissa, M.; Strano, S.; Zacchi, P.; Mantovani, R.; Blandino, G.; Del Sal, G. Pinl links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 2004, 14, 625-636.
19. Monje, P.; Hernandez-Losa, J.; Lyons, R. J.; Castellone, M. D.; Gutkind, J. S. Regulation of the transcriptional activity of c-Fos by ERK: a novel role for the prolyl isomerase Pinl. J. Biol. Chem. 2005, 250, 35081-35084.
20. Ryo, A.; Suizu, F.; Yoshida, Y.; Perrem, K; Liou, Y. C.; Wulf, G.; Rottapel, R.; Yamaoka, S.; Lu, K. P. Regulation of NF-kB signaling by Pin1-dependent proly1 isomerization and ubiquitinmediated proteolysis of p65/RelA. Mo0I. Cell 2003, 12, 1413-1426.
21. Ryo, A.; Nakamura, N.; Wulf, G.; Liou, Y. C.; Lu, K. P. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC Nat. Cell Biol. 2001, 5, 793-801.
22. Chen, S. Y.; Wulf, G.; Zhou, X. Z.; Rubin, M. A.; Lu, K. P.; Balk, S. P. Activation of β-catenin signaling in prostate cancer by peptidylprolyl isomerase Pinl-mediated abrogation of the androgen receptor-β-catenin interaction. Mol. Cell. Biol. 2006, 26, 929-939.
23. Lu, K. P.; Hanes, S. D.; Hunter, T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380, 544-547.
24. Winkler, K. E.; Swenson, K. I.; Kornbluth, S.; Means, A. R. Requirement of the prolyl isomerase Pinl for the replication checkpoint. Science 2000, 287, 1644-1647.
25. Rippmann, J. F.; Hobbie, S.; Daiber, C.; Guilliard, B.; Bauer, M.; Birk, J.; Nar, H.; Garin-Chesa, P.; Rettig, W. J.; Schnapp, A. Phosphorylation- dependent proline isomerization catalyzed by Pinl is essential for tumor survival and entry into mitosis. Cell Growth Differ. 2000, 11, 409-416.
26. Uchida, T.; Takamiya, M.; Takahashi, M.; Miyashita, H.; Ikeda, H.; Terada, T.; Matsuo, Y.; Shirouzu, M.; Yokoyama, S.; Fujimori, F.; Hunter, T. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 2003, 10, 15-24.
27. Hennig, L.; Christner, C.; Kipping, M.; Schelbert, B.; Rucknagel, K. P.; Grabley, S.; Kullertz, G.; Fischer, G. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998, 37, 5953-5960.
28. Daum, S.; Erdmann, F.; Fischer, G.; Feaux de Lacroix, B.; Hessamian-Alinejad, A.; Houben, S.; Frank, W.; Braun, M. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pinl. Angew. Chem., Int. Ed. 2006, 45, 7454-7458.
29. Braun, M.; Hessamian-Alinejad, A.; Feaux de Lacroix, B.; Alvarez, B. H.; Fischer, G. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl isomerase Pin1. Molecules 2008, 13, 995-1003.
30. Tatara, Y.; Lin, Y.-C.; Bamba, Y.; Mori, T.; Uchida, T. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1. Biochem. Biophys. Res. Commun. 2009, 384, 394-398.
31. Guo, C.; Hou, X.; Dong, L.; Dagostino, E.; Greasley, S.; Ferre, R.; Marakovits, J.; Johnson, M. C.; Matthews, D.; Mroczkowski, B.; Parge, H.; Vanarsdale, T.; Popoff, I.; Piraino, J.; Margosiak, S.; Thomson, J.; Los, G.; Murray, B. W. Structure-based design of novel human Pin1 inhibitors (I). Bioorg. Med. Chem. Lett. 2009, 19, 5613-5616.
32. Zhang, Y.; Fussel, S.; Reimer, U.; Schutkowski, M.; Fischer, G. Substrate-based design of reversible Pin1 inhibitors. Biochemistry 2002, 41, 11868-11877.
33. Wang, X. J.; Xu, B. L.; Mullins, A. B.; Neiler, F. K.; Etzkorn, F. A. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J. Am. Chem. Soc. 2004, 126, 15533-15542.
34. Bayer, E.; Thutewohl, M.; Christner, C.; Tradler, T.; Osterkamp, F.; Waldmann, H.; Bayer, P. Identification of hPin1 inhibitors that induce apoptosis in a mammalian Ras transformed cell line. Chem. Commun. 2005, 516-518.
35. Wildemann,D.; Erdmann,F.; Alvarez,B. H.; Stoller, G.; Zhou, X. Z.; Fanghanel, J.; Schutkowski, M.; Lu, K. P.; Fischer, G. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J. Med. Chem. 2006, 49, 2147-2150.
36. Zhang, Y.; Daum, S.; Wildemann, D.; Zhou, X. Z.; Verdecia, M. A.; Bowman, M. E.; Lucke, C.; Hunter, T.; Lu, K. P.; Fischer, G.; Noel, J. P. Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2007, 2, 320-328.
37. Zhang, Y.; Zhou, S. G.; Wavreille, A. S.; DeWille, J.; Pei, D. Cyclic peptidyl inhibitors of Grb2 and tensin SH2 domains identified from combinatorial libraries. J. Comb. Chem. 2008, 10, 247-255.
38. Shen, M.; Stukenberg, P. T.; Kirschner, M. W.; Lu, K. P. The essential mitotic peptidyl-prolyl isomerase Pin 1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998, 12, 706-720.
39. Thakkar, A.; Wavreille, A.-S.; Pei, D. Traceless capping agent for peptide sequencing by partial Edman degradation and mass spectrometry. Anal. Chem. 2006, 78, 5935-5939.
40. Kofron, J. L.; Kuzmic, P.; Kishore, V.; Colonbonilla, E.; Rich, D. H. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 1991, 30, 6112-6134.
41. Wavreille, A. S.; Pei, D. A chemical approach to the identification of tensin-binding proteins. ACS Chem. Biol. 2007, 2, 109-118.
42. Reineke, E. L.; Lam, M.; Liu, O.; Liu, Y.; Stanya, K. J.; Chang, K. S.; Means, A. R.; Kao, H. Y. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol. Cell. Biol. 2008, 28, 997-1006.
43. Stanya, K. J.; Liu, Y.; Means, A. R.; Kao, H. Y. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. J. Cell Biol. 2008, 183, 49-61.
44. Wildemann, D.; Alvarez, B. H.; Stoller, G.; Zhou, X. Z.; Lu, K.-P.; Erdmann, F.; Ferrari, D.; Fischer, G. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors. Biol. Chem. 2007, 388, 1103-1111.
45. Vives, E.; Brodin, P.; Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997, 272, 16010-16017.
46. Joo, S. H.; Xiao, Q.; Ling, Y.; Gopishetty, B.; Pei, D. High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry. J. Am. Chem. Soc. 2006, 128, 13000-13009.
47. Liu, T.; Joo, S. H.; Voorhees, J. L.; Brooks, C. L.; Pei, D. Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg. Med. Chem. 2009, 17, 1026-1033.